The influence of acupuncture TENS currents on the proliferation of cancer cells tested in vitro

Introduction: Transcutaneous Electrical Nerve Stimulation (TENS) is a very popular, non-pharmacological antianalgetic method. Nonetheless, knowledge on using this method is very limited in the treatment of patients with cancer anamnesis. Unfortunately, there are not many results of research referring to the application of this method. It is much more difficult to exclude the possibility of proneoplastic activity regarding these methods than to confirm this action. Aim: The aim of the study was to evaluate the influence of TENS currents on the proliferation of cancer cells tested in vitro. Materials and methods: The following human cell lines were used - A549, ES-2, HT29, MCF-7. The cells were plated 24 h before treatment. Then, the cells were exposed to AL-TENS currents (0.1 mA, 1.0 mA and 10 mA), t imp. 200μs; f 2Hz, constant; duration: 20 min. The in vitro cytotoxic effects were examined after 96 h in SRB assay. In the other experiment, there were three expositions – 24, 48 and 72 hours from the beginning of the experiment. Results: In this assay, the acceleration of cancer cell proliferation after single or triple-dose expositions to AL-TENS currents was not observed. Conclusions: The AL-TENS current after repeated doses did not accelerate proliferation of cancer cells in in vitro conditions.

Download Full-text

The Iinfluence TENS H Current Over Proliferation of Cancer Cells Depending on the Intensity in in vitro Assay

Acta Balneologica ◽

10.36740/abal201903110 ◽

2019 ◽

Vol 61 (3) ◽

pp. 213-216

Author(s):

Marzena Pełczyńska ◽

Magdalena Milczarek ◽

Magdalena Maciejewska ◽

Joanna Wietrzyk

Keyword(s):

Cancer Cells ◽

In Vitro Assay ◽

Cytotoxic Effects ◽

Vitro Assay ◽

Patients With Cancer ◽

Neoplastic Process ◽

Repeated Doses ◽

Triple Dose ◽

Mcf 7

Introduction: The knowledge of influence physiotherapeutic method over proliferation process is insufficient. It is considered that electrotherapeutic methods could accelerate neoplastic process. Thus using this methods are very limited in treatment patients with cancer anamnesis. Unfortunately, there are in literature not a lot of results of base researches in this area. It is much more difficult to exclude possibility proneoplastic activity of this methods than confirm this action. Aim: of the study is checking the influence of TENS current over proliferation of cancer cells in in vitro assay. Materials and Methods: The following human cell lines were used- A549, ES-2, HT29, MCF-7. The cells were plated twenty-four hours before treatment. Then the cells were exposured to TENS H current (0,1 mV and 1mV), t imp.100μs; f 100Hz, constant; during 20 min. The in vitro cytotoxic effects were examined after 96h in SRB assay. In the other experiment there were three- times expositions – 24, 48 and 72 hours after the plated. Results: In this assay it wasn’t observed the acceleration of proliferation of cancer cells after single dose or triple dose expositions to TENS H current. Conclusion: The TENS H current after repeated doses didn’t accelerate proliferation of cancer cells in in vitro conditions.

Download Full-text

Application of new ZnO nanoformulation and Ag/Fe/ZnO nanocomposites as water-based nanofluids to consider in vitro cytotoxic effects against MCF-7 breast cancer cells

Artificial Cells Nanomedicine and Biotechnology ◽

10.1080/21691401.2017.1290643 ◽

2017 ◽

Vol 45 (8) ◽

pp. 1769-1777 ◽

Cited By ~ 11

Author(s):

Mohammad Hossein Abdolmohammadi ◽

Faranak Fallahian ◽

Zahra Fakhroueian ◽

Mozhgan Kamalian ◽

Peyman Keyhanvar ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Cytotoxic Effects ◽

Water Based ◽

Mcf 7

Download Full-text

New Neo-Lignan From Acanthopanax senticosus and the Cytotoxic Effects on Human Cancer Cell Lines

Natural Product Communications ◽

10.1177/1934578x20941299 ◽

2020 ◽

Vol 15 (7) ◽

pp. 1934578X2094129

Author(s):

Zhi-Chao Feng ◽

Sheng Wang ◽

Jun Li ◽

Jun-Sheng Wang

Keyword(s):

Cancer Cells ◽

Inhibitory Concentration ◽

Human Cancer ◽

In Vitro Cytotoxicity ◽

Soluble Extract ◽

Acanthopanax Senticosus ◽

Cytotoxic Effects ◽

Human Cancer Cell Lines ◽

Mcf 7

A new neo-lignan named (7ʹ S,8ʹ R)-4ʹ,5ʹ,9ʹ-trihydroxy-5-methoxy-4,8ʹ-oxyneolign-7-en-9-al (1), together with 5 known compounds (2-6) were isolated from the ethylacetate-soluble extract of Acanthopanax senticosus. The structure of new neo-lignan was elucidated with spectroscopic and physicochemical analyses. All the isolates were evaluated for in vitro cytotoxicity against 4 human cancer lines including HepG2, A549, Hela, and MCF-7. Among them, compounds 1 and 3 showed the potent antiproliferative activities against the HepG2 cancer cells with half-maximal inhibitory concentration (IC50) values of 9.8 ± 1.6 and 15.0 ± 1.1 μM, respectively. In addition, compound 6 exhibited moderate inhibitory activity on MCF-7 cancer cells with an IC50 value of 18.3 ± 1.5 μM.

Download Full-text

In Vitro Inhibition of Hsp90 Protein by Benzothiazoloquinazolinequinones Is Enhanced in The Presence of Ascorbate. A Preliminary In Vivo Antiproliferative Study

Molecules ◽

10.3390/molecules25040953 ◽

2020 ◽

Vol 25 (4) ◽

pp. 953 ◽

Cited By ~ 2

Author(s):

Jaime A. Valderrama ◽

David Ríos ◽

Giulio G. Muccioli ◽

Pedro Buc Calderon ◽

Julio Benites

Keyword(s):

Cancer Cells ◽

Cancer Cell ◽

Cancer Cell Proliferation ◽

Current Standard ◽

In Vivo Animal Model ◽

Ic50 Values ◽

Mtt Reduction ◽

Mcf 7

A series of benzo[g]benzothiazolo[2,3-b]quinazoline-7,12-quinones were prepared from 2-acylnaphthohydroquinones and 2-aminobenzothiazoles and were evaluated for their in vitro antiproliferative activity. After screening using the MTT reduction assay, their IC50 values were calculated on a panel of cancer cells (T24, DU-145, MCF-7). Current standard anticancer drugs were included as control, and their calculated IC50 values were 7.8 and 23.5 µM for 5-fluorouracil and tamoxifen, respectively. Non-cancer cells (AG1523) were included to assess cancer cell sensitivity and drug selectivity. Four members of the series, with IC50 values from 0.11 to 2.98 µM, were chosen for further assays. The selected quinones were evaluated regarding their effects on cancer cell proliferation (clonogenic assay) and on Hsp90 and poly(ADPribose)polymerase (PARP) protein integrity. The most active compound (i.e., 15) substantially inhibited colony forming unit (CFU) formation at 0.25 µM. In the presence of ascorbate, it induced an oxidative cleavage of Hsp90 but had no effect on PARP protein integrity. In an in vivo animal model, it discreetly increased the mean survival time (m.s.t.) of tumor-bearing mice. In light of these results, compound 15 represents a potential lead-molecule to be further developed.

Download Full-text

Induction of Apoptosis and Regulation of MicroRNA Expression by (2E,6E)-2,6-bis-(4-hydroxy-3-methoxybenzylidene)-cyclohexanone (BHMC) Treatment on MCF-7 Breast Cancer Cells

Molecules ◽

10.3390/molecules26051277 ◽

2021 ◽

Vol 26 (5) ◽

pp. 1277

Author(s):

Swee Keong Yeap ◽

Norlaily Mohd Ali ◽

Muhammad Nadeem Akhtar ◽

Nursyamirah Abd Razak ◽

Zhi Xiong Chong ◽

...

Keyword(s):

Breast Cancer ◽

Cell Cycle ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Quantitative Polymerase Chain Reaction ◽

M Cell ◽

Cytotoxic Effects ◽

Er Positive ◽

Mcf 7

(2E,6E)-2,6-bis-(4-hydroxy-3-methoxybenzylidene)-cyclohexanone (BHMC) is a synthetic curcumin analogue, which has been reported to possess anti-tumor, anti-metastatic, and anti-invasion properties on estrogen receptor (ER) negative breast cancer cells in vitro and in vivo. However, the cytotoxic effects of BHMC on ER positive breast cancer cells were not widely reported. This study was aimed to investigate the cytotoxic potential of BHMC on MCF-7 cells using cell viability, cell cycle, and apoptotic assays. Besides, microarray and quantitative polymerase chain reaction (qPCR) were performed to identify the list of miRNAs and genes, which could be dysregulated following BHMC treatment. The current study discovered that BHMC exhibits selective cytotoxic effects on ER positive MCF-7 cells as compared to ER negative MDA-MB-231 cells and normal breast cells, MCF-10A. BHMC was shown to promote G2/M cell cycle arrest and apoptosis in MCF-7 cells. Microarray and qPCR analysis demonstrated that BHMC treatment would upregulate several miRNAs like miR-3195 and miR-30a-3p and downregulate miRNAs such as miR-6813-5p and miR-6132 in MCF-7 cells. Besides, BHMC administration was also found to downregulate few tumor-promoting genes like VEGF and SNAIL in MCF-7. In conclusion, BHMC induced apoptosis in the MCF-7 cells by altering the expressions of apoptotic-regulating miRNAs and associated genes.

Download Full-text

Cytotoxic effects of disulfiram and synergism with cisplatin on ovarian cancer cells in vitro

10.1055/s-0038-1671352 ◽

2018 ◽

Author(s):

F Guo ◽

Z Yang ◽

J Xu ◽

J Sehouli ◽

AE Albers ◽

...

Keyword(s):

Ovarian Cancer ◽

Cancer Cells ◽

Ovarian Cancer Cells ◽

Cytotoxic Effects

Download Full-text

Anticancer Potential of Calli Versus Seedling Extracts Derived from Rosmarinus officinalis and Coleus hybridus

Current Pharmaceutical Biotechnology ◽

10.2174/1389201021666200318114817 ◽

2020 ◽

Vol 21 (14) ◽

pp. 1528-1538

Author(s):

Sarah Albogami ◽

Hadeer Darwish ◽

Hala M. Abdelmigid ◽

Saqer Alotaibi ◽

Ahmed Nour El-Deen ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Transcriptional Profiling ◽

Significant Inhibition ◽

Rosmarinus Officinalis ◽

Crude Extracts ◽

Incidence And Mortality ◽

Mcf 7

Background: In Saudi Arabia, the incidence and mortality rates of breast cancer are high. Although current treatments are effective, breast cancer cells develop resistance to these treatments. Numerous studies have demonstrated that active compounds in plant extracts, such as the phenolic compound Rosmarinic Acid (RA), exert anti-cancer effects. Objective: We investigated the anticancer properties of methanolic crude extracts of seedlings and calli of Rosmarinus officinalis and Coleus hybridus, two Lamiaceae species. Methods: MCF-7 human breast cancer cells were treated with methanolic crude extracts obtained from plant calli and seedlings generated in vitro, and cell proliferation was evaluated. Transcriptional profiling of the seedling and callus tissues was also conducted. Results: The mRNA expression levels of RA genes were higher in C. hybridus seedlings than in R. officinalis seedlings, as well as in C. hybridus calli than in R. officinalis calli, except for TAT and C4H. In addition, seedling and callus extracts of both R. officinalis and C. hybridus showed anti-proliferative effects against MCF-7 cells after 24 or 48 h of treatment. Discussion: At a low concentration of 10 μg/mL, C. hybridus calli and seedling extracts showed the most significant anti-proliferative effects after 24 and 48 h of exposure (p < 0.01); controls (doxorubicin) also showed significant inhibition, but lesser than that observed with C. hybridus (p < 0.05). Results with R. officinalis callus and seedling extracts did not significantly differ from those with untreated cells. Conclusion: Methanolic extracts of R. officinalis and C. hybridus are potentially valuable options for breast cancer treatment.

Download Full-text

A Novel Triazole Derivative Drug Presenting In Vitro and In Vivo Anticancer Properties

Current Topics in Medicinal Chemistry ◽

10.2174/1568026618666180917100640 ◽

2018 ◽

Vol 18 (17) ◽

pp. 1483-1493

Author(s):

Ricardo Imbroisi Filho ◽

Daniel T.G. Gonzaga ◽

Thainá M. Demaria ◽

João G.B. Leandro ◽

Dora C.S. Costa ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Cell Line ◽

Cancer Cell ◽

Cancer Cell Line ◽

Hepatic Function ◽

Anticancer Properties ◽

Mcf 7

Background: Cancer is a major cause of death worldwide, despite many different drugs available to treat the disease. This high mortality rate is largely due to the complexity of the disease, which results from several genetic and epigenetic changes. Therefore, researchers are constantly searching for novel drugs that can target different and multiple aspects of cancer. Experimental: After a screening, we selected one novel molecule, out of ninety-four triazole derivatives, that strongly affects the viability and proliferation of the human breast cancer cell line MCF-7, with minimal effects on non-cancer cells. The drug, named DAN94, induced a dose-dependent decrease in MCF-7 cells viability, with an IC50 of 3.2 ± 0.2 µM. Additionally, DAN94 interfered with mitochondria metabolism promoting reactive oxygen species production, triggering apoptosis and arresting the cancer cells on G1/G0 phase of cell cycle, inhibiting cell proliferation. These effects are not observed when the drug was tested in the non-cancer cell line MCF10A. Using a mouse model with xenograft tumor implants, the drug preventing tumor growth presented no toxicity for the animal and without altering biochemical markers of hepatic function. Results and Conclusion: The novel drug DAN94 is selective for cancer cells, targeting the mitochondrial metabolism, which culminates in the cancer cell death. In the end, DAN94 has been shown to be a promising drug for controlling breast cancer with minimal undesirable effects.

Download Full-text

In Vitro Evaluation of Chitosan Induced Cytotoxicity against Cancerous Cell lines: MCF-7, Saos-2 and HeLa

Anti-Cancer Agents in Medicinal Chemistry ◽

10.2174/1871520619666190507113949 ◽

2019 ◽

Vol 19 ◽

Author(s):

Zeinab Abedian ◽

Niloofar Jenabian ◽

Ali Akbar Moghadamnia ◽

Ebrahim Zabihi ◽

Roghayeh Pourbagher ◽

...

Keyword(s):

Flow Cytometry ◽

Cell Lines ◽

Anticancer Agents ◽

Fibroblast Cells ◽

Apoptosis Induction ◽

Cytotoxic Effects ◽

Cancerous Cell ◽

Significant Concentration ◽

Mcf 7

Objective/ Background: Cancer is still the most common cause of morbidity in world and new powerful anticancer agents without severe side effects from natural sources is important. Methods: The evaluation of cytotoxicity and apoptosis induction was carried out in MCF-7,HeLa and Saos-2 as cancerous cell lines with different histological origin and human fibroblast served as control normal cell. The cells were treated with different concentrations of chitosan and the cytotoxicity was determined using MTT assay after 24, 48 and 72 h .The mode of death was evaluated by flow cytometry . Results: While both types of chitosan showed significant concentration-dependently cytotoxic effects against the three cancerous cell lines, fibroblast cells showed somehow more compatibility with chitosan. On the other hand, there were no significant differences between LMWC and HMWC cytotoxicity in all cell lines. The flow cytometry results showed the apoptosis pattern of death more in Saos-2 and HeLa while necrosis was more observable with MCF7. Also higher viability with both types of chitosan was seen in fibroblast as normal cells Conclusion: Chitosan shows anticancerous effect against 3 cancerous cell lines, while it is compatible with normal diploid fibroblast cells. Furthermore, it seems that the molecular weight of chitosan does not affect its anticancerous property.

Download Full-text

In vitro evaluation of estrogenic, antiestrogenic and antitumor effects of amentoflavone

Human & Experimental Toxicology ◽

10.1177/0960327121999454 ◽

2021 ◽

pp. 096032712199945

Author(s):

AT Aliyev ◽

S Ozcan-Sezer ◽

A Akdemir ◽

H Gurer-Orhan

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Antitumor Effects ◽

Antiestrogenic Activity ◽

Er Positive ◽

In Vivo Effects ◽

Mcf 7

Apigenin, a flavonoid, is reported to act as an estrogen receptor (ER) agonist and inhibit aromatase enzyme. However, amentoflavone, a biflavonoid bearing two apigenin molecules, has not been evaluated for its endocrine modulatory effects. Besides, it is highly consumed by young people to build muscles, enhance mood and lose weight. In the present study, apigenin was used as a reference molecule and ER mediated as well as ER-independent estrogenic/antiestrogenic activity of amentoflavone was investigated. Antitumor activity of amentoflavone was also investigated in both ER positive (MCF-7 BUS) and triple-negative (MDA-MB-231) breast cancer cells and its cytotoxicity was evaluated in human breast epithelial cells (MCF-10A). Our data confirmed ER agonist, aromatase inhibitory and cytotoxic effects of apigenin in breast cancer cells, where no ER mediated estrogenic effect and physiologically irrelevant, slight, aromatase inhibition was found for amentoflavone. Although selective cytotoxicity of amentoflavone was found in MCF-7 BUS cells, it does not seem to be an alternative to the present cytotoxic drugs. Therefore, neither an adverse effect, mediated by an estrogenic/antiestrogenic effect of amentoflavone nor a therapeutical benefit would be expected from amentoflavone. Further studies could be performed to investigate its in vivo effects.

Download Full-text